Vitale G, Gitto S, Vukotic R, Raimondi F, Andreone P. Familial intrahepatic cholestasis: new and wide perspectives. Dig Liver Dis. 2019;51:922–33. https://doi.org/10.1016/J.DLD.2019.04.013/ASSET/D0C16C98-9DA9-4CA4-843A-DDCB5D5F52D4/MAIN.ASSETS/GR2.SML.
Article CAS PubMed Google Scholar
Baker A, Kerkar N, Todorova L, Kamath BM, Houwen RHJ. Systematic review of progressive familial intrahepatic cholestasis. Clin Res Hepatol Gastroenterol. 2019;43:20–36. https://doi.org/10.1016/J.CLINRE.2018.07.010.
Ruiz-Casas L, O’Hara S, Mighiu C, Finnegan A, Taylor A, Ventura E, Dhawan A, Murray KF, Schattenberg J, Willemse J, et al. Burden of illness of progressive familial intrahepatic cholestasis in the US, UK, France, and Germany: study rationale and protocol of the PICTURE Study. Expert Rev Pharmacoecon Outcomes Res. 2021;21:247–53. https://doi.org/10.1080/14737167.2021.1859371/SUPPL_FILE/IERP_A_1859371_SM4029.DOCX.
Bull LN, Thompson RJ. progressive familial intrahepatic cholestasis. Clin Liver Dis. 2018;22:657–69. https://doi.org/10.1016/J.CLD.2018.06.003.
Gao E, Cheema H, Waheed N, Mushtaq I, Erden N, Nelson-Williams C, Jain D, Soroka CJ, Boyer JL, Khalil Y, et al. organic solute transporter alpha deficiency: a disorder with cholestasis, liver fibrosis, and congenital diarrhea. Hepatology. 2020;71:1879–82. https://doi.org/10.1002/HEP.31087.
Sultan M, Rao A, Elpeleg O, Vaz FM, Abu-Libdeh B, Karpen SJ, Dawson PA. Organic solute transporter-beta (SLC51B) deficiency in two brothers with congenital diarrhea and features of cholestasis. Hepatology. 2018;68:590. https://doi.org/10.1002/HEP.29516.
Article CAS PubMed Google Scholar
Stalke A, Sgodda M, Cantz T, Skawran B, Lainka E, Hartleben B, Baumann U, Pfister ED. KIF12 variants and disturbed hepatocyte polarity in children with a phenotypic spectrum of cholestatic liver disease. J Pediatr. 2022;240:284-291.e9. https://doi.org/10.1016/j.jpeds.2021.09.019.
Article CAS PubMed Google Scholar
Luan W, Hao CZ, Li JQ, Wei Q, Gong JY, Qiu YL, Lu Y, Shen CH, Xia Q, Xie XB, et al. Biallelic loss-of-function ZFYVE19 mutations are associated with congenital hepatic fibrosis, sclerosing cholangiopathy and high-GGT cholestasis. J Med Genet. 2021;58:514–25. https://doi.org/10.1136/JMEDGENET-2019-106706.
Article CAS PubMed Google Scholar
Vitale G, Mattiaccio A, Conti A, Turco L, Seri M, Piscaglia F, Morelli MC. Genetics in familial intrahepatic cholestasis: clinical patterns and development of liver and biliary cancers: a review of the literature. Cancers. 2022;14:3421. https://doi.org/10.3390/CANCERS14143421.
Article CAS PubMed PubMed Central Google Scholar
Gwaltney C, Ivanescu C, Karlsson L, Warholic N, Kjems L, Horn P. Validation of the PRUCISION instruments in pediatric patients with progressive familial intrahepatic cholestasis. Adv Ther. 2022;39:5105–25. https://doi.org/10.1007/S12325-022-02262-7.
Article CAS PubMed PubMed Central Google Scholar
Pan Q, Luo G, Qu J, Chen S, Zhang X, Zhao N, Ding J, Yang H, Li M, Li L, et al. A homozygous R148W mutation in semaphorin 7A causes progressive familial intrahepatic cholestasis. EMBO Mol Med. 2021. https://doi.org/10.15252/EMMM.202114563.
Article PubMed PubMed Central Google Scholar
Home – OMIM. https://www.omim.org/. Accessed 26 Apr 2023.
Gunaydin M, Tugce A, Cil B. Progressive familial intrahepatic cholestasis: diagnosis, management, and treatment. Hepat Med. 2018. https://doi.org/10.2147/HMER.S137209.
Article PubMed PubMed Central Google Scholar
Fiche Info - ACIDE URSODESOXYCHOLIQUE BIOGARAN 250 Mg, Comprimé Pelliculé - Base de Données Publique Des Médicaments. https://base-donnees-publique.medicaments.gouv.fr/extrait.php?specid=60970141. Accessed 10 Aug 2023.
van Wessel DBE, Thompson RJ, Gonzales E, Jankowska I, Sokal E, Grammatikopoulos T, Kadaristiana A, Jacquemin E, Spraul A, Lipiński P, et al. Genotype correlates with the natural history of severe bile salt export pump deficiency. J Hepatol. 2020;73:84–93. https://doi.org/10.1016/J.JHEP.2020.02.007.
Thompson RJ, Arnell H, Artan R, Baumann U, Calvo PL, Czubkowski P, Dalgic B, D’Antiga L, Durmaz Ö, Fischler B, et al. Odevixibat treatment in progressive familial intrahepatic cholestasis: a randomised, placebo-controlled, phase 3 trial. Lancet Gastroenterol Hepatol. 2022;7:830–42. https://doi.org/10.1016/S2468-1253(22)00093-0.
Article CAS PubMed Google Scholar
Biyoukar M, Corpechot C, El Mouhadi S, Chambenois E, Vanderbecq Q, Barbu V, Dong C, Lemoinne S, Tordjman M, Jomaah R, et al. A BCB4 variant is associated with hepatobiliary MR abnormalities in people with low-phospholipid-associated cholelithiasis syndrome. JHEP Rep. 2022. https://doi.org/10.1016/J.JHEPR.2022.100590.
Article PubMed PubMed Central Google Scholar
Luketic VA, Shiffman ML. Benign recurrent intrahepatic cholestasis. Clin Liver Dis. 2004;8:133–49. https://doi.org/10.1016/S1089-3261(03)00133-8.
Nayagam JS, Williamson C, Joshi D, Thompson RJ. Review article: liver disease in adults with variants in the cholestasis-related genes ABCB11, ABCB4 and ATP8B1. Aliment Pharmacol Ther. 2020;52:1628–39. https://doi.org/10.1111/APT.16118.
Article CAS PubMed Google Scholar
Vitale G, Mattiaccio A, Conti A, Berardi S, Vero V, Turco L, Seri M, Morelli MC. Molecular and clinical links between drug-induced cholestasis and familial intrahepatic cholestasis. 2023. https://doi.org/10.3390/ijms24065823
Vitale G, Gitto S, Raimondi F, Mattiaccio A, Mantovani V, Vukotic R, D’Errico A, Seri M, Russell RB, Andreone P. Cryptogenic cholestasis in young and adults: ATP8B1, ABCB11, ABCB4, and TJP2 gene variants analysis by high-throughput sequencing. J Gastroenterol. 2018;53:945–58. https://doi.org/10.1007/S00535-017-1423-1/METRICS.
Article CAS PubMed Google Scholar
Nayagam JS, Foskett P, Strautnieks S, Agarwal K, Miquel R, Joshi D, Thompson RJ. Clinical phenotype of adult-onset liver disease in patients with variants in ABCB4, ABCB11, and ATP8B1. Hepatol Commun. 2022;6:2654–64. https://doi.org/10.1002/HEP4.2051.
Article CAS PubMed PubMed Central Google Scholar
Ovadia C, Seed PT, Sklavounos A, Geenes V, Di Illio C, Chambers J, Kohari K, Bacq Y, Bozkurt N, Brun-Furrer R, et al. Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses. Lancet. 2019;393:899–909. https://doi.org/10.1016/S0140-6736(18)31877-4.
Article PubMed PubMed Central Google Scholar
Kruk B, Milkiewicz M, Raszeja-Wyszomirska J, Milkiewicz P, Krawczyk M. A common variant in the hepatobiliary phospholipid transporter ABCB4 modulates liver injury in PBC but not in PSC: prospective analysis in 867 patients. Orphanet J Rare Dis. 2022;17:419. https://doi.org/10.1186/S13023-022-02565-6.
Article PubMed PubMed Central Google Scholar
Kim I, Morimura K, Shah Y, Yang Q, Ward JM, Gonzalez FJ. Spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice. Carcinogenesis. 2007;28:940–6. https://doi.org/10.1093/CARCIN/BGL249.
Article CAS PubMed Google Scholar
Clayton RJ, Iber FL, Ruebner BH, Mckusick VA. Byler disease: fatal familial intrahepatic cholestasis in an amish kindred. Am J Dis Child. 1969;117:112–24. https://doi.org/10.1001/archpedi.1969.02100030114014.
Article CAS PubMed Google Scholar
Carlton VEH, Knisely AS, Freimer NB. Mapping of a locus for progressive familial intrahepatic cholestasis (byler disease) to 18q21-Q22, the benign recurrent intrahepatic cholestasis region. Hum Mol Genet. 1995;4:1049–53. https://doi.org/10.1093/hmg/4.6.1049.
Article CAS PubMed Google Scholar
Van Mil SWC, Van Der Woerd WL, Van Der Brugge G, Sturm E, Jansen PLM, Bull LN, Van Den Berg IET, Berger R, Houwen RHJ, Klomp LWJ. Benign recurrent intrahepatic cholestasis type 2 is caused by mutations in ABCB11. Gastroenterology. 2004;127:379–84. https://doi.org/10.1053/J.GASTRO.2004.04.065.
Marleen J, De Vree L, Jacquemin E, Cresteil D, Bosma PJ, Aten J, Deleuze J-F, Desrochers M, Burdelski M, Bernard O, et al. Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis. Med Sci. 1998;95:282–7.
Gužvić M. The history of DNA sequencing. J Med Biochem
留言 (0)